Navigation Links
PulmoBioTech Announces Details of Its Regulatory Approval Experiments
Date:4/24/2008

NEW YORK, April 24 /PRNewswire-FirstCall/ -- PulmoBioTech Inc. (OTC Bulletin Board: PLMO) announced today that its PulmoScience subsidiary has released details of the areas that it will be investigating as part of the Regulatory Approval Experiments for Human Trials. The areas are:

1. Efficacy Binding Studies

2. Characterization of Drug Product Impurities

3. Sterility Studies

4. Pyrogenicity

5. Immunological Testing

6. Dosimetry

7. Toxicity

PulmoScience will be completing all the relevant tests in each area and seeking Regulatory sign-off before starting the detailed Human Trials. This is currently expected to be achieved in the first half of 2008.

About PulmoBioTech Inc.

PulmoBioTech Inc. specializes in the development and marketing of medical technology and research. Our proven strengths combine extensive commercial experience and academic credentials. The principal staff members are acknowledged experts in their specialized field, and work with a broad range of investment institutions. PulmoBioTech's mission is to utilize scientific imagination and drive, together with managerial and financial acumen, to bring innovative and profitable products to the marketplace to the benefit of all stock holders.

About PulmoScience Inc.

PulmoScience Inc. was established in 2006, and is currently developing a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind.

The company was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by PulmoBioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and ex
'/>"/>

SOURCE PulmoBioTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... A lot of discussion in the medical community revolves ... injuries, or conditions. As medical science advances, doctors and surgeons ... that they consider to be more cutting edge. Yet, when ... method of treatment that stands out as the best solution ...
(Date:1/23/2015)... 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), ... operable and inoperable solid tumor cancers, announced today that CEO ... Annual Phacilitate Immunotherapy Forum in Washington D.C. ... take place on January 26 at 10:30 a.m. EST at ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... , First-of-its-Kind Study Demonstrates REMICADE More Likely to Maintain ... , , CHICAGO, June 2 New ... with moderately to severely active Crohn,s disease having inadequate ... biologic therapy, were presented at Digestive Disease Week today. ...
... Insights into the Prediction of IBD Using Serology Testing ... Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic ... important serologic marker used in the detection of Crohn,s ... for celiac disease. In an oral presentation yesterday at ...
Cached Medicine Technology:New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 2New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 3New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 4New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 5New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 6New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 7New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 8New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease 9Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 3
(Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... giants Cadbury have to pay heavily for the salmonella ... failed to inform the concerned authority about the possible ... of chocolates at their factory. They had supplied these ... many consumers. This was the breach of General Food ...
... It is a known fact that alcohol abuse and/or ... damage. //It is also known that women, more than ... a shorter period of drinking and with less overall ... also sustain greater cognitive damage than male alcoholics. ...
... achieving one of today’s Science greatest goals: allowing humans to ... well as from the UGR, researchers from the Spanish universities ... in this study, concluding that the consumption of melatonin – ... and present in many types of food – delays the ...
... has lodged a complaint with the West Bengal Human ... a patient died because the management// allegedly stopped medication ... 57, died on Saturday at the Mission of Mercy ... April 18 with diabetes, abdominal problem and cardiac ailments. ...
... Rajasthan will be fitted with an electronic biometric attendance system ... initially installed in a few primary schools, but later will ... first be installed in 15 schools of Jaipur and five ... already reached Bikaner. Initially, it would be used on an ...
... article published by the British Medical journal reveals that there has ... in the Asian region. This has become a// major strain on ... report the number of cases are expected to climb at the ... 156 to 100,000 as compared to 164 to 100,000 in the ...
Cached Medicine News:Health News:Cadbury Indicted on Salmonella Scare 2Health News:Cognitive Problems Occur More Rapidly in Female Alcoholics Than in Males 2Health News:Cognitive Problems Occur More Rapidly in Female Alcoholics Than in Males 3Health News:High Melatonin can Help Delay Ageing 2Health News:NRI Doctor Protests Patient's Death in Kolkata Hospital 2Health News:Cancer Time Bomb Threatening Economic Infrastructure 2